SPINEMarketGroup

The company reports with a low consensus bar, record earnings and a question Wall Street has yet to answer: why does the stock still trade at a discount? On Thursday, November 5, after the market close, Globus Medical (NYSE: GMED) will release its third-quarter 2026 results. On paper, it is just another earnings report. In practice, it could be … [Read More...] about Record Earnings, Discount Valuation: What Globus Medical Must Prove on November 5

Ecully, October 15, 2026 NINE-MONTH REVENUE: €8 MILLION Continued structuring to optimize supply and support the growth strategy Appointment of Erwan Martin as Deputy Chief Executive Officer Spineway, a specialist in innovative implants for the treatment of severe spine disorders, recorded revenue of €2.3 million for the third quarter of 2026, compared with €3.0 million in the same … [Read More...] about Spineway : Nine-Month Revenue

GALWAY, Ireland, Oct. 15, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the Stealth AXiS™ surgical system and the Corsano™* multi-parameter wearable have been named to the TIME Best Inventions of 2026 list. The annual award highlights the most impactful new products and ideas of the year, … [Read More...] about Medtronic Named to TIME Best Inventions of 2026 List for Stealth AXiS™ surgical system and Corsano™* multi-parameter wearable

WEST CHESTER, Pa., Oct. 14, 2026 /PRNewswire/ -- Centinel Spine®, LLC ("the Company"), a commercial-stage medical technology company focused exclusively on total disc replacement (TDR) and advancing motion-preserving solutions for the cervical and lumbar spine, today announced that it has received U.S. Food and Drug Administration (FDA) approval for two-level use of the prodisc® C … [Read More...] about Centinel Spine® Receives FDA Approval for Two-Level Use of prodisc® C Nova, Further Expanding the Match-The-Disc™ Cervical Portfolio

New Innovations Designed to Advance Patient-Specific Planning and Connected Surgical Workflows AUDUBON, Pa., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will highlight its latest spine innovations at the 41st Annual North American Spine Society (NASS) Meeting in San Antonio, Texas, from October … [Read More...] about Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026

CARLSBAD, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the U.S. commercial launch of its aprevo® Lumbar Bi-lateral Posterior System at the North American Spine Society’s 41st Annual Meeting (NASS) in San Antonio, TX. The launch follows a limited market evaluation that commenced in February 2026, with the first in … [Read More...] about Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System

Next-generation posterior cervical implant pairs 3D-printed porous titanium with the clinically proven CORUS™ PCSS design SAN ANTONIO, Oct. 13, 2026 /PRNewswire/ -- Providence Medical Technology, Inc., the leader in Total Segmental Fusion, stabilizing all three joints of the spinal segment with technology backed by Level 1 clinical evidence, today announced that it has received 510(k) … [Read More...] about Providence Medical Technology Receives FDA 510(k) Clearance for CORUS™ PCSS 3D-T, Bringing 3D-Printed Porous Titanium to Its Total Segmental Fusion Platform

A single-surgeon case series using Ruthless Spine’s RJB trajectory guidance system reports no reoperations for screw malposition across 44 lumbar fusion cases and 264 pedicle screws. The study, authored by Shane S. Pak, MD, covers surgeries performed over a 21-month period at three community hospitals, none with more than 300 beds. All patients were treated as inpatients and followed for at least … [Read More...] about RJB Tablet-Based Guidance Delivers Clean Results in Single-Surgeon Lumbar Fusion Series

South Korean medical device maker CG MedTech has received regulatory clearance in Colombia for INNOVERSE, its posterior spinal fixation system, and will bring the product to market through local partner IMPLAMEQ. The company said last Wednesday that Colombia’s National Institute for Food and Drug Surveillance (INVIMA) granted the device Class IIb approval on Sept. 30. Surgeons use INNOVERSE to … [Read More...] about CG MedTech Gets INVIMA Approval for INNOVERSE Spinal System in Colombia

PARIS, October 08, 2026 – 6:00 pm CEST - SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces its third quarter 2026 revenue. Pierre Jérôme, Co-founder, Chairman and CEO of SpineGuard, stated: “The third … [Read More...] about SpineGuard announces its Q3 revenue

BOCA RATON, Fla.--(BUSINESS WIRE)--SurGenTec®, a privately held medical device company focused on advancing treatment options for orthopedic and spine surgery, today announced that it has entered into an exclusive license agreement with Allevion Medical for its patented Vantage™ spinal decompression technology. Under the terms of the agreement, SurGenTec® has secured exclusive rights to … [Read More...] about SurGenTec® Enters Exclusive License Agreement with Allevion Medical for Vantage™ Spinal Decompression System

The disc replacement company turned a $10.2 million profit in the first half and plans to trade on the NYSE as CNTL. Centinel Spine has filed for an initial public offering in the United States, reporting a 42% increase in revenue for the first half of 2026, according to Reuters. The West Chester, Pennsylvania, company has built its business entirely around total disc replacement (TDR), and the … [Read More...] about Centinel Spine Files for NYSE IPO After 42% Jump in First-Half Revenue